IP Library › Assignment 058529/0980
Patent Assignment
Reel/Frame 058529/0980

Assignment of Assignor's Interest

Recorded: 2022-01-03 Pages: 5
Assignors
DEAN, NICHOLAS M.
Executed: 2009-11-12
FOULKES, J. GORDON
Executed: 2009-11-12
O'DONNELL, NIALL
Executed: 2009-11-12
Assignee
EXCALIARD PHARMACEUTICALS, INC.
2141 PALOMAR AIRPORT RD., SUITE 300, CARLSBAD, CALIFORNIA, 92011
Covered Properties (2)
Methods for Inhibiting Expression of Connective Tissue Growth Factor
Patent: 8,772,260 →
Application: 13/584,573 →
Publication: US 2013/0190382
Antisense Oligonucleotides Directed Against Connective Tissue Growth Factor and Uses Thereof
Patent: 9,688,987 →
Application: 14/753,860 →
Publication: US 2015/0376623
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Dec 16, 2016
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 040998/0017 →
Change of Name Jun 15, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 042832/0349 →
Assignment of Assignor's Interest Jan 3, 2022
From: BENNETT, C. FRANK; FREIER, SUSAN M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 058530/0014 →